Hydrea (Hydroxyurea)

The active ingredient in HYDREA is hydroxyurea. Fact Table Formula CH4N2O2 License AU, EU EMA, US FDA Bioavailability - Legal status RX Only Chemical Name Hydroxyurea Elimination half-life 2-4 hours Dosage (Strength) 500mg (100 capsules) Pregnancy Consult a doctor Brands Droxia, Hydrea, Siklos Protein binding - PubChem CID 3657 MedlinePlus a682004 ChEBI 44423 ATC code L01XX05 DrugBank DB01005 KEGG D00341 Routes of administration Oral

The oncologist should reduce the dose by 50% in people with moderate to severe kidney impairment. HYDREA should not be used while pregnant and can cause harm to a developing fetus. HYDREA causes bone marrow suppression (myelosuppression). A complete blood count (CBC) will need to be monitored regularly during treatment. HYDREA increases sensitivity to the sun and artificial sources of ultraviolet (UV)

Side effects with HYDREA are common and can be severe. Tell your oncologist if you are experiencing any of the following: Acute mucocutaneous toxicity, Anemia, Asthma, Dermatological reaction, Eczema, Fever, Headache, Infection, Leg ulcer, Macrocytosis, Neutropenia, Thrombocytopenia, Vitamin D deficiency, Weight gain Dr. Sheehy (BSc Molecular Biology, PharmD) works a clinical pharmacist specializing in cardiology, oncology, and ambulatory care. He’s a board-certified pharmacotherapy specialist (BCPS), and his experience working one-on-one with patients to fine tune their medication and therapy plans for optimal results makes him a valuable subject matter expert for our pharmacy.Read More....